The antimicrobial treatment of consumer products has expanded dramatically over the past two decades, moving well beyond its origins in medical and food processing applications into a category of everyday consumer goods where its presence is, at best, unnecessary and, at worst, actively counterproductive. Textiles are where this expansion has been most aggressive and most consequential for everyday household microbiome exposure — and the bath towel is the single most striking example of how far this trend has traveled from anything defensible by the evidence.
THE ANTIMICROBIAL TEXTILE INDUSTRY
The antimicrobial textile market emerged from legitimate applications: medical textiles in hospital settings, where reducing bacterial load on wound dressings and surgical materials is genuinely important; athletic performance wear, where the odor-causing bacteria that colonize sweat-saturated fabric are a real and commercially meaningful problem; and food processing environments, where antimicrobial surfaces reduce contamination risk. In each of these contexts, the antimicrobial treatment had a specific, documentable function that justified its application.
What followed was the migration of this technology into consumer textiles with no equivalent justification — bath towels, bed sheets, underwear, children’s clothing, yoga mats, cutting boards, kitchen sponges, and dozens of other everyday household items now marketed with antimicrobial claims built on the extrapolation that fewer bacteria on any surface is always better. This extrapolation is incorrect, and the evidence for its incorrectness is increasingly robust.
WHAT THE TREATMENTS ARE
Triclosan — the most studied antimicrobial additive in textiles and the one whose regulatory history is most instructive — was incorporated into consumer textiles, plastics, and personal care products for decades before the FDA determined in 2016 that there was insufficient evidence that triclosan in consumer antiseptic wash products provided greater benefit than plain soap and water, and sufficient evidence of endocrine disruption risk to warrant its removal from those products. Triclosan in textiles is regulated separately from rinse-off personal care products and remains present in some consumer textile applications.
Silver nanoparticles are the replacement technology most widely adopted following triclosan’s regulatory pressure in personal care applications. Silver has genuine and well-documented antimicrobial properties — it disrupts bacterial cell membranes and enzyme function through mechanisms that make bacterial resistance difficult to develop, which is one reason silver-based wound dressings are clinically useful in medical settings. Consumer textiles impregnated with silver nanoparticles release silver ions during laundering and during wear — releasing them into the wastewater system, into the home laundry water, and onto the skin of the person wearing or using the treated textile.
The environmental concern with silver nanoparticle release from textiles is documented: studies have found that silver released from antimicrobial textiles during laundering significantly reduces the diversity of the beneficial bacteria in wastewater treatment systems that process the laundry runoff. The concern for the skin microbiome is analogous — silver released from a treated bath towel during use contacts the skin surface and its microbial community with every drying, applying a broad-spectrum antimicrobial pressure to the skin microbiome with every use, multiple times daily.
Zinc pyrithione, copper-based treatments, and quaternary ammonium compounds permanently bonded to textile fibers are additional antimicrobial agents used in consumer textiles, each with varying release profiles and varying evidence for both efficacy in the consumer application and safety for the skin microbiome they contact.
THE SKIN MICROBIOME: WHY IT MATTERS
The skin microbiome — the approximately 1.8 square meters of microbial ecosystem that covers the human body — is not an incidental colonization to be periodically eliminated. It is an active participant in skin barrier function, immune training, pathogen defense, and inflammatory regulation that has co-evolved with human biology over millennia.
Specific skin microbiome organisms — particularly Staphylococcus epidermidis — produce compounds that inhibit the colonization of pathogenic Staphylococcus aureus, including MRSA. Others produce fatty acids that maintain skin surface pH in the acidic range that is unfavorable to pathogen colonization. Others participate in the immune education of the skin’s resident immune cells — training the local immune response to tolerate commensal organisms while remaining alert to genuine pathogens.
The antimicrobial treatment of the textiles that spend the most time in contact with skin — bath towels, bed sheets, clothing, particularly underwear — applies broad-spectrum antimicrobial pressure to this ecosystem with every use. Broad-spectrum antimicrobials do not selectively eliminate pathogens while preserving commensals. They reduce microbial populations indiscriminately, and the organisms most resistant to a given antimicrobial agent — which are not necessarily the ones most beneficial to the host — tend to be the ones that survive and repopulate the treated surface and, by extension, the skin.
WHAT TO DO INSTEAD
The odor problem that antimicrobial textiles are primarily sold to solve is a bacterial fermentation problem — sweat itself is odorless; it is the bacterial metabolism of sweat components that produces odor compounds. The solution to this problem that does not involve continuous antimicrobial pressure on the skin microbiome is washing — the mechanical and surfactant removal of bacteria and their metabolic products from the textile, which addresses odor at its source without the residual antimicrobial effect that follows the textile into the next use.
Natural fibers — particularly wool and linen, but also high-quality cotton — have inherently lower bacterial proliferation rates than synthetic fibers because their physical structure and moisture management properties create less favorable conditions for bacterial growth. Wool in particular has demonstrated natural antimicrobial properties from its lanolin content that reduce odor development without the industrial antimicrobial treatment required by synthetic performance fabrics. These properties do not produce the continuous skin microbiome disruption that industrial antimicrobial treatments create, because they operate through physical and chemical mechanisms that are selective in their effects rather than broadly biocidal.
For bath towels specifically — the product where the antimicrobial marketing is most incongruous with any genuine need — organic cotton or linen towels washed regularly in hot water with a fragrance-free detergent perform identically to antimicrobially treated towels for their actual function and deliver a skin microbiome-neutral drying experience that no treated product can match.
The antimicrobial label on a consumer textile is not a safety feature. It is a marketing feature applied to a product whose contact with the skin microbiome would benefit from its absence.